Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F3P4L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,611
Award facts
- Contract value 100% obligated
- $40,610.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded January 13, 2026, provides RINVOQ ER 15 mg tablets (30-count units) to the Defense Logistics Agency (DLA) through a firm fixed-price contract valued at $40,610.82, with an ultimate completion date of January 14, 2026. The award was made to AmerisourceBergen Drug Corp, the corporate office division of Cencora, Inc., located in Conshohocken, Pennsylvania. This contract was not set aside and was competitively awarded, reflecting the contractor's demonstrated capability to meet federal pharmaceutical procurement requirements. The delivery order is expected to be completed within one day of award, indicating this represents a time-sensitive medical supply requirement.
This delivery order operates under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The IDC enables the company to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and other medical commodities across multiple therapeutic domains. The DLA Troop Support Medical leverages this prime vendor arrangement to fulfill critical medication needs for military treatment facilities, the Defense Health Agency, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F3P4L?
SPE2DR26F3P4L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F3P4L worth?
The government has obligated $40,611 on SPE2DR26F3P4L.
Is contract SPE2DR26F3P4L an order under another contract?
Yes. SPE2DR26F3P4L is a delivery order under SPE2DR25D3008, an indefinite delivery contract.
Was contract SPE2DR26F3P4L competed?
The extent of competition for SPE2DR26F3P4L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award